NCT07417306: A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Type 2 Diabetes